Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05571410 · ClinicalTrials.gov registry record · NA
BP PAL - Hypertension Chat Bot Pilot
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT05571410: Completed NA study, sponsored by University of Pennsylvania.
NCT05571410 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05571410, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
A 2-arm randomized pilot trial aimed at evaluating the effectiveness of a 6-month remote monitoring program for the management of hypertension (HTN). 300 eligible patients will be randomized in a 1:1 ratio into two recruitment arms: A) Control (usual care), or B) Remote monitoring via automated messaging program. The target population are patients at the Penn Family Medicine University City and Westtown primary care practices with baseline poor blood pressure control as indicated by two blood pressures greater than 140/90 within the past twelve month including the most recent measurement and on at least one anti-hypertensive agent.
Interventions
- BEHAVIORAL HTN Chat bot
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-01-09 |
| Est. Completion | 2023-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05571410
The ClinicalTrials.gov registry entry for NCT05571410 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HTN Chat bot is the first listed.
NCT05571410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05571410 about?
NCT05571410 is a clinical study titled "BP PAL - Hypertension Chat Bot Pilot". A 2-arm randomized pilot trial aimed at evaluating the effectiveness of a 6-month remote monitoring program for the management of hypertension (HTN). 300 eligible patients will be randomized in a 1:1 ratio into two recruitment arms: A) Control (usual care), or B) Remote monitoring via automated mess...
What is the current status of trial NCT05571410?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2023-01-09. Estimated completion is 2023-10-31.
What interventions are being tested in trial NCT05571410?
The interventions under investigation include: HTN Chat bot (BEHAVIORAL).
Who is sponsoring clinical trial NCT05571410?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.